Orient Europharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
May 12, 2021 at 04:49 am IST
Share
Orient EuroPharma Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 1,214.933 million compared to TWD 1,549.959 million a year ago. Operating income was TWD 20.264 million compared to TWD 211.597 million a year ago. Net income was TWD 5.757 million compared to TWD 118.041 million a year ago. Basic earnings per share from continuing operations was TWD 0.07 compared to TWD 1.36 a year ago.
Orient Europharma Co., Ltd. is principally engaged in the manufacture and distribution of nutritious healthcare products and medical cosmetic products, as well as western drugs. The Company operates nutritious healthcare products and medical cosmetic products segment, providing infant milk powders, nutritious products and functional healthcare products, as well as dermatological preparations, medical hair care series, organic skin care series and medical make-up products, among others; western drugs segment, providing products for cardiovascular diseases, cancer, blood diseases, diabetes, central nervous system diseases and asthma, among others.
ORIENT EUROPHARMA CO., LTD. 
